Skip to main content
. 2022 Jun 9;16(11):E528–E532. doi: 10.5489/cuaj.7802

Table 3.

Time to subsequent therapy after first-line treatment for SCPC

Value, n (%)
Time to second-line of treatment (months) All: 12
Nonmetastatic: 13
Metastatic: 8
Time to third-line of treatment (months) 7
Time to fourth-line of treatment (months) 1 patient: 7 months

SCPC: small cell prostate carcinoma.